%0 Journal Article
%T Patient
%A J. Sanford Schwartz
%A Joseph J. Gallo
%A Marsha N. Wittink
%A Ravishankar Jayadevappa
%A S. Bruce Malkowicz
%A Sumedha Chhatre
%J MDM Policy & Practice
%@ 2381-4683
%D 2019
%R 10.1177/2381468319855375
%X Objectives. To describe the development of our Patient Preferences for Prostate Cancer Care (PreProCare) tool to aid patient-centered treatment decision among localized prostate cancer patients. Methods. We incorporated patient and provider experiences to develop a patient preference elicitation tool using adaptive conjoint analysis. Our patient-centered approach used systematic literature review, semistructured patient interviews, and provider focus groups to determine the treatment attributes most important for decision making. The resulting computer-based PreProCare tool was pilot tested in a clinical setting. Results. A systematic review of 56 articles published between 1995 and 2015 yielded survival, cancer recurrence, side effects, and complications as attributes of treatment options. We conducted one-on-one interviews with 50 prostate cancer survivors and 5 focus groups of providers. Patients reported anxiety, depression, treatment specifics, and caregiver burden as important for decision making. Providers identified clinical characteristics as important attribute. Input from stakeholders¡¯ advisory group, physicians, and researchers helped finalize 15 attributes for our PreProCare preference assessment tool. Conclusion. The PreProCare tool was developed using a patient-centered approach and may be a feasible and acceptable preference clarification intervention for localized prostate cancer patients. The PreProCare tool may translate into higher participant engagement and self-efficacy, consistent with patients¡¯ personal values
%K adaptive conjoint analysis
%K patient-centered care
%K preference
%K prostate cancer
%K treatment
%U https://journals.sagepub.com/doi/full/10.1177/2381468319855375